Company / R&D per Share
IDEAYA Biosciences, Inc. R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.64
FY2025
5-year range
$1.03 / $4.53
FY2021-FY2025
Trend
-19.7%
vs FY2024
Sector context
#57 of 208
Health Care
What the data says
At $3.64, IDEAYA Biosciences, Inc.'s r&d per share ranks #57 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 9 years, ranging from $1.03 in FY2022 to $33.20 in FY2018.
Based on SEC 10-K filings.
3.64 in FY2025 with a 5-year CAGR of +18.4%.
Improved from $2.69 to $3.64 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +52.3%
- 5-Year CAGR
- +18.4%
- 10-Year CAGR
- -
Sector benchmark
#57 of 208 in Health CareTop 27% of 208This company $3.64 Sector average $12.19
▼
-70.2% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 19.7% year-over-year.
- Ranks #57 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2018.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.64 | -19.7% |
| FY2024 | $4.53 | +68.6% |
| FY2023 | $2.69 | +160.8% |
| FY2022 | $1.03 | -11.3% |
| FY2021 | $1.16 | -25.6% |
| FY2020 | $1.56 | -43.2% |
| FY2019 | $2.75 | -91.7% |
| FY2018 | $33.20 | +86.4% |
| FY2017 | $17.81 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026